Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
63.99B
Market cap63.99B
Price-Earnings ratio
17.90
Price-Earnings ratio17.90
Dividend yield
Dividend yield
Average volume
23.40M
Average volume23.40M
High today
$43.76
High today$43.76
Low today
$42.68
Low today$42.68
Open price
$43.20
Open price$43.20
Volume
25.51M
Volume25.51M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$42.25
52 Week low$42.25

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $43.00. The company's market cap stands at 63.99B, with a P/E ratio of 17.90.

On 2026-07-01, Boston Scientific(BSX) stock moved within a range of $42.68 to $43.76. With shares now at $43.00, the stock is trading +0.7% above its intraday low and -1.7% below the session's peak.

Trading volume for Boston Scientific(BSX) stock has reached 25.51M, versus its average volume of 23.4M.

The stock's 52-week range extends from a low of $42.25 to a high of $109.50.

The stock's 52-week range extends from a low of $42.25 to a high of $109.50.

BSX News

MarketWatch 1d
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch

...

Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
TipRanks 1d
Boston Scientific’s POLARx Study Completion Adds Fresh Data to Atrial Fibrillation Growth Story

Boston Scientific (BSX) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for...

TipRanks 7d
Boston Scientific price target lowered to $65 from $75 at Stifel

Stifel lowered the firm’s price target on Boston Scientific (BSX) to $65 from $75 and keeps a Buy rating on the shares after the firm hosted five deep left atri...

Analyst ratings

85%

of 34 ratings
Buy
85.3%
Hold
14.7%
Sell
0%

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.